Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

MilliporeSigma has about 1,700 employees in Wisconsin at facilities in Milwaukee, Port Washington, Sheboygan and in the ...

while in life science, it seeks to support biopharmaceutical companies in China with breakthrough technologies in areas like ...

Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

data-text="Merck Announces Emerging Biotech Grant Program Winners" data-link=" Announces Emerging Biotech Grant Program ...

Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 ...

As AI becomes more prevalent, organizations need to leverage the power of scope, scale, speed, and human-AI collaboration for ...

Award recipients to receive in-kind technologies and services to accelerate therapeutics to market <li /> Merck e ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.